Published in Thromb Haemost on March 01, 2003
Weighted gene coexpression network analysis strategies applied to mouse weight. Mamm Genome (2007) 3.59
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis (2012) 1.83
Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev (2009) 1.62
Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgery. J Neurosurg (2012) 1.54
Nutritional management of a patient with obesity and pulmonary embolism: a case report. Nutr J (2016) 1.38
The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int (2016) 1.36
New insights into the mechanisms of venous thrombosis. J Clin Invest (2012) 1.32
Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med (2006) 1.27
Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy. Surg Endosc (2014) 1.25
Activated partial thromboplastin time and risk of future venous thromboembolism. Am J Med (2008) 1.12
Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England. Hum Reprod (2011) 1.08
Characterization of coagulation factor synthesis in nine human primary cell types. Sci Rep (2012) 1.06
American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc (2015) 1.03
Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol (2010) 0.98
Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics (2011) 0.94
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol (2010) 0.85
Obesity and hormonal contraceptive efficacy. Womens Health (Lond Engl) (2013) 0.85
Obesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2010) 0.82
Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study. Obes Surg (2015) 0.79
99mTc-apcitide scintigraphy in patients with clinically suspected deep venous thrombosis and pulmonary embolism. Eur J Nucl Med Mol Imaging (2008) 0.79
Cardiovascular Consequences of Obesity and Targets for Treatment. Drug Discov Today Ther Strateg (2008) 0.78
Epidemiology of recurrent venous thrombosis. Braz J Med Biol Res (2011) 0.78
Outcome of patients with pulmonary embolism admitted to the intensive care unit. Ann Thorac Med (2009) 0.78
Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. J Womens Health (Larchmt) (2011) 0.78
Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thromb Res (2016) 0.77
Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis. Medicine (Baltimore) (2016) 0.77
Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: Incidence, Analysis and Follow-Up in 1236 Consecutive Cases. Obes Surg (2016) 0.77
Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res (2016) 0.77
Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients. Clin Chim Acta (2010) 0.77
Targets to treat metabolic syndrome in polycystic ovary syndrome. Expert Opin Ther Targets (2015) 0.76
Practice patterns in high-risk bariatric venous thromboembolism prophylaxis. Surg Endosc (2012) 0.76
Changes in Dietary Fat Content Rapidly Alters the Mouse Plasma Coagulation Profile without Affecting Relative Transcript Levels of Coagulation Factors. PLoS One (2015) 0.76
Response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. MedGenMed (2005) 0.75
Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery. Eur Thyroid J (2016) 0.75
Levonorgestrel Intrauterine Device Use in Overweight and Obese Women. Hawaii J Med Public Health (2015) 0.75
A unique presentation of four thrombotic events at a time. BMJ Case Rep (2012) 0.75
Contraception and the obese woman. J Am Assoc Nurse Pract (2013) 0.75
Improving Awareness and Outcomes Related to Venous Thromboembolism. JAMA (2015) 0.75
Thrombosis in Inherited Fibrinogen Disorders. Transfus Med Hemother (2017) 0.75
Hemodynamic effects of electrical muscle stimulation in the prophylaxis of deep vein thrombosis for intensive care unit patients: a randomized trial. J Intensive Care (2017) 0.75
Nomegestrol acetate-17b-estradiol for oral contraception. Patient Prefer Adherence (2013) 0.75
Obesity in pregnancy: risks and management. Obstet Med (2009) 0.75
Diabetes mellitus and risk of deep vein thrombosis after total knee replacement: a meta-analysis of cohort studies. Int J Clin Exp Med (2015) 0.75
Comparing the Excessive Daytime Sleepiness of Obese and Non-obese Patients. Iran Red Crescent Med J (2016) 0.75
Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study. PLoS One (2017) 0.75
Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives. Front Endocrinol (Lausanne) (2017) 0.75
Role of routine pre-operative screening venous duplex ultrasound in morbidly obese patients undergoing bariatric surgery. J Minim Access Surg (2017) 0.75
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005) 6.16
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA (2005) 5.46
Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet (2011) 4.27
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90
Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67
Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA (2007) 3.50
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
Risk assessment for recurrent venous thrombosis. Lancet (2010) 3.31
Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA (2006) 3.26
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15
A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14
Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med (2006) 3.13
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance? Lancet (2003) 2.98
Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med (2006) 2.75
Gene variants associated with deep vein thrombosis. JAMA (2008) 2.74
Osteoarthritis of the knee: association between clinical features and MR imaging findings. Radiology (2006) 2.62
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ (2013) 2.45
Hypoglycemia is associated with intensive care unit mortality. Crit Care Med (2010) 2.41
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol (2009) 2.37
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32
Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev (2014) 2.28
Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med (2009) 2.26
Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J (2006) 2.22
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med (2009) 2.16
Risks of oral anticoagulant therapy with increasing age. Arch Intern Med (2005) 2.06
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. Arch Intern Med (2004) 2.00
Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med (2007) 1.98
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ (2011) 1.96
Is an EMA review on hormonal contraception and thrombosis needed? BMJ (2013) 1.94
Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke (2005) 1.94
C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation (2003) 1.93
Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol (2008) 1.93
Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol (2007) 1.89
Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke (2013) 1.89
A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood (2002) 1.86
Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke (2011) 1.86
Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis. Aging Cell (2009) 1.85
Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol (2008) 1.84
Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke (2007) 1.84
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med (2010) 1.83
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med (2009) 1.81
Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80
Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2012) 1.79
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood (2011) 1.78
Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol (2013) 1.78
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol (2004) 1.72
Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.72
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
Multiple SNP testing improves risk prediction of first venous thrombosis. Blood (2012) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation (2014) 1.69
Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation (2007) 1.69
Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol (2004) 1.69
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood (2013) 1.69
Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev (2007) 1.67
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem (2008) 1.65
Association between urinary albumin excretion and coronary heart disease in black vs white adults. JAMA (2013) 1.65
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation (2014) 1.64
Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol (2008) 1.64
Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2011) 1.63
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol (2007) 1.61
Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol (2012) 1.60